New therapeutic modalities in the treatment of graft-versus-host disease
โ Scribed by N. Basara; M.G. Kiehl; A.A. Fauser
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 105 KB
- Volume
- 38
- Category
- Article
- ISSN
- 1040-8428
No coin nor oath required. For personal study only.
โฆ Synopsis
The Department for Bone Marrow Transplantation and Hematology/Oncology was founded in 1994. Performing 90 transplantations per year it is one of the largest transplant centers in Germany, focusing on unrelated stem cell transplantations. Our extensive basic and clinical research programme is also contributing to new strategies in the prevention and treatment of severe GvHD.
๐ SIMILAR VOLUMES
Extracorporeal photochemotherapy (ECP; photopheresis), an immunomodulatory therapy developed for cutaneous T-cell lymphoma, has shown promise in treating chronic graft-versus-host disease (cGvHD) in uncontrolled studies. The purpose of this study was to further examine the effects of ECP on cGvHD. E
Nineteen patients with acute graft versus host disease (GvHD) following bone marrow transplantation (BMT) were treated with high dose bolus 6-methylprednisolone (BMPr), at the dose of 20 mg/kg/day i.v. for the first 3 days, 10 mg/kg/day i.v. for the following 4 days, and then at doses gradually tape